Skip to main content

Table 2 Gene Expression Data for Esophageal Cancer Patients in the ICU After POD 14

From: Prognostic impact of clinical course-specific mRNA expression profiles in the serum of perioperative patients with esophageal cancer in the ICU: a case control study

Pt.# SCC
(ng/mL)
Cytokeratin fragment 19
(ng/mL)
CEA
(ng/mL)
hTERTmRNA
(logarithmic copy number)
Recurrence Depth of tumor
invasion
#1 2.4 2.5 - 3.31 - Mp
#2 - - - 3.9 - Sm
#3 0.9 1.5 - 2.96 + Ss
#4 < 0.5 1.4 - 4.41 - Sm
#5 - - - 0 - M
#6 2.0 1.6 - 0 + Ss
#7 0.9 0.9 - 4.96 - Sm
#8 < 0.5 1.9 - 0 - Ss
#9 1.1 1.3 3.8 2.97 - Ss
#10 1.2 2.1 1.0 3.58 - Ss
#11 - - - 2.75 - Ss
#12 0.8 0.9 - 2.14 - Ss
#13 1.6 2.7 1.4 4.61 - Sm
#14 2.7 - 3.1 3.99 - Ss
#15 0.9 3.0 - 3.84 - Ss
#16 - - - 3.81 - Sm
#17 1.6 7.4 - 4.14 - Mp
#18 1.3 0.9 2.4 4.53 - Sm
#19 0.7 2.5 - 4.11 - Sm
#20 3.9 3.1 2.4 4.41 - Ss
#21 2.9 - 3.5 3.44 - Mp
#22 0.7 2.2 - 4.35 - Sm
#23 < 0.5 1.4 - 4.03 - Ss
#24 1.4 - - 3.89 - M
#25 1.2 1.4 - 3.35 - Ss
#26 - - - 4.39 - M
#27 0.7 0.9 2.3 4.45 - Mp
  1. -: not measured